About
Technology
Issues
FAQ
Links
Official Page
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.